Firmenbeschreibung
Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Free float (75%),Triton GP HoldCo SARL (10%),Novo Holdings A/S (8%),Mubadala Investment Company (7%) |
sharesOutstanding: | 177553456.0000 |
ceo: | Dr Christian Wojczewski |
board: | Paul Hitchin, Dr. Cord Dohrmann, Aurélie Dalbiez |
supervisoryBoard: | Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Camilla Macapili Languille, Dr. Duncan McHale, Wes Wheeler, Roland Sackers |
countryID: | 2 |
freeFloat: | 62.1900 |
faceValueCurrencyID: | 1 |
faceValueCurrency: | EUR |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | Deutschland |
countryName: | Deutschland |
Kontakt
name: | Volker Braun |
phone: | +49-40-56081-775 |
fax: | +49-40-56081-222 |
email: | InvestorRelations@evotec.com |
irWebSite: | https://www.evotec.com/en/investor-relations |
Adresse
street: | Essener Bogen 7 |
city: | D-22419 Hamburg |
phone: | +49-40-56081-0 |
fax: | +49-40-56081-222 |
webSite: | www.evotec.com |
email: | info@evotec.com |
Finanzen (kurz)
year: | 2022 | cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 | liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 | sales: | 751.4500 |
investment: | 8.3400 | incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 | employees: | 4952 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2023 | cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 | liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 | sales: | 781.4260 |
investment: | 9.2630 | incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 | employees: | 5061 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2024 | cash: | 306.3870 |
balanceSheetTotal: | 1912.5020 | liabilities: | 959.9770 |
totalShareholdersEquity: | 952.5250 | sales: | 796.9670 |
investment: | 2.4350 | incomeBeforeTaxes: | -193.9770 |
netIncome: | -196.0780 | employees: | 4827 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
Finanzen (kurz)
year: | 2022 |
cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 |
liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 |
sales: | 751.4500 |
investment: | 8.3400 |
incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 |
employees: | 4952 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2023 |
cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 |
liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 |
sales: | 781.4260 |
investment: | 9.2630 |
incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 |
employees: | 5061 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2024 |
cash: | 306.3870 |
balanceSheetTotal: | 1912.5020 |
liabilities: | 959.9770 |
totalShareholdersEquity: | 952.5250 |
sales: | 796.9670 |
investment: | 2.4350 |
incomeBeforeTaxes: | -193.9770 |
netIncome: | -196.0780 |
employees: | 4827 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 2252.4680 | cash: | 510.9090 |
currentAssets: | 903.1620 | fixedAssets: | 1349.3060 |
liabilities: | 464.5730 | nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 | provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 | employees: | 5061 |
property: | 806.5630 | intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 | inventories: | 30.8900 |
accountsReceivable: | 98.3960 | accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 | longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 | minorityInterests: | 0.0000 |
sales: | 781.4260 | netIncome: | -83.9130 |
operatingResult: | -47.5070 | incomeInterest: | -2.4760 |
investments: | 68.5290 | incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 | grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 | cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 | accountingStandard: | IFRS |
equityRatio: | 49.7192 | debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 | liquidityII: | 131.1538 |
netMargin: | -10.7384 | grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 | ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 | preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 | roe: | -7.4928 |
roa: | -3.7254 | netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 | taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 | epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 | incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 | bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 | earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 | netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 | netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 | units: | 1000000 |
balanceSheetTotal: | 1912.5020 | cash: | 306.3870 |
currentAssets: | 681.9640 | fixedAssets: | 1230.5380 |
liabilities: | 344.5850 | nonCurrentLiabilities: | 615.3920 |
totalLiabilitiesEquity: | 1912.5020 | provisions: | 81.8040 |
totalShareholdersEquity: | 952.5250 | employees: | 4827 |
property: | 823.9370 | intangibleAssets: | 26.4410 |
longTermInvestments: | 2.1380 | inventories: | 90.4130 |
accountsReceivable: | 116.3190 | accountsPayable: | 85.7920 |
liabilitiesTotal: | 959.9770 | longTermDebt: | 392.7430 |
shortTermDebt: | 50.7950 | minorityInterests: | 0.0000 |
sales: | 796.9670 | netIncome: | -196.0780 |
operatingResult: | -142.5220 | incomeInterest: | -9.2640 |
investments: | 50.8570 | incomeTaxes: | 2.1020 |
costGoodsSold: | 682.0860 | grossProfit: | 114.8810 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 165106.0700 |
cashFlow: | 18.2200 | cashFlowInvesting: | -71.1870 |
cashFlowFinancing: | -161.4210 | accountingStandard: | IFRS |
equityRatio: | 49.8052 | debtEquityRatio: | 100.7823 |
liquidityI: | 88.9148 | liquidityII: | 122.6710 |
netMargin: | -24.6030 | grossMargin: | 14.4148 |
cashFlowMargin: | 2.2862 | ebitMargin: | -17.8830 |
ebitdaMargin: | 0.0000 | preTaxROE: | -20.3645 |
preTaxROA: | -10.1426 | roe: | -20.5851 |
roa: | -10.2524 | netIncomeGrowth: | 133.6682 |
revenuesGrowth: | 1.9888 | taxExpenseRate: | -1.0836 |
equityTurnover: | 0.8367 | epsBasic: | -1.1100 |
epsBasicGrowth: | 136.1702 | incomeBeforeTaxes: | -193.9770 |
priceCashFlowRatio: | 79.8601 | bookValuePerShare: | 5.3647 |
marketCap: | 1455050571.9200 | earningsYield: | -13.5448 |
cashFlowPerShare: | 0.1026 | netAssetsPerShare: | 5.3647 |
priceBookValueRatio: | 1.5276 | netEarningsPerShare: | -1.1043 |
currency: | EUR |
year: | 2025 | priceCashFlowRatio: | 62.3289 |
bookValuePerShare: | 5.3647 | marketCap: | 1135631904.5760 |
earningsYield: | -17.3546 | pegRatio: | -0.0423 |
cashFlowPerShare: | 0.1026 | netAssetsPerShare: | 5.3647 |
priceBookValueRatio: | 1.1922 | netEarningsPerShare: | -1.1043 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 2252.4680 |
cash: | 510.9090 |
currentAssets: | 903.1620 |
fixedAssets: | 1349.3060 |
liabilities: | 464.5730 |
nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 |
provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 |
employees: | 5061 |
property: | 806.5630 |
intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 |
inventories: | 30.8900 |
accountsReceivable: | 98.3960 |
accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 |
longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 |
minorityInterests: | 0.0000 |
sales: | 781.4260 |
netIncome: | -83.9130 |
operatingResult: | -47.5070 |
incomeInterest: | -2.4760 |
investments: | 68.5290 |
incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 |
grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 |
cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 |
accountingStandard: | IFRS |
equityRatio: | 49.7192 |
debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 |
liquidityII: | 131.1538 |
netMargin: | -10.7384 |
grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 |
ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 |
roe: | -7.4928 |
roa: | -3.7254 |
netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 |
taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 |
epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 |
incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 |
bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 |
earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 |
netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 |
netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 |
units: | 1000000 |
balanceSheetTotal: | 1912.5020 |
cash: | 306.3870 |
currentAssets: | 681.9640 |
fixedAssets: | 1230.5380 |
liabilities: | 344.5850 |
nonCurrentLiabilities: | 615.3920 |
totalLiabilitiesEquity: | 1912.5020 |
provisions: | 81.8040 |
totalShareholdersEquity: | 952.5250 |
employees: | 4827 |
property: | 823.9370 |
intangibleAssets: | 26.4410 |
longTermInvestments: | 2.1380 |
inventories: | 90.4130 |
accountsReceivable: | 116.3190 |
accountsPayable: | 85.7920 |
liabilitiesTotal: | 959.9770 |
longTermDebt: | 392.7430 |
shortTermDebt: | 50.7950 |
minorityInterests: | 0.0000 |
sales: | 796.9670 |
netIncome: | -196.0780 |
operatingResult: | -142.5220 |
incomeInterest: | -9.2640 |
investments: | 50.8570 |
incomeTaxes: | 2.1020 |
costGoodsSold: | 682.0860 |
grossProfit: | 114.8810 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 165106.0700 |
cashFlow: | 18.2200 |
cashFlowInvesting: | -71.1870 |
cashFlowFinancing: | -161.4210 |
accountingStandard: | IFRS |
equityRatio: | 49.8052 |
debtEquityRatio: | 100.7823 |
liquidityI: | 88.9148 |
liquidityII: | 122.6710 |
netMargin: | -24.6030 |
grossMargin: | 14.4148 |
cashFlowMargin: | 2.2862 |
ebitMargin: | -17.8830 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -20.3645 |
preTaxROA: | -10.1426 |
roe: | -20.5851 |
roa: | -10.2524 |
netIncomeGrowth: | 133.6682 |
revenuesGrowth: | 1.9888 |
taxExpenseRate: | -1.0836 |
equityTurnover: | 0.8367 |
epsBasic: | -1.1100 |
epsBasicGrowth: | 136.1702 |
incomeBeforeTaxes: | -193.9770 |
priceCashFlowRatio: | 79.8601 |
bookValuePerShare: | 5.3647 |
marketCap: | 1455050571.9200 |
earningsYield: | -13.5448 |
cashFlowPerShare: | 0.1026 |
netAssetsPerShare: | 5.3647 |
priceBookValueRatio: | 1.5276 |
netEarningsPerShare: | -1.1043 |
currency: | EUR |
year: | 2025 |
priceCashFlowRatio: | 62.3289 |
bookValuePerShare: | 5.3647 |
marketCap: | 1135631904.5760 |
earningsYield: | -17.3546 |
pegRatio: | -0.0423 |
cashFlowPerShare: | 0.1026 |
netAssetsPerShare: | 5.3647 |
priceBookValueRatio: | 1.1922 |
netEarningsPerShare: | -1.1043 |
currency: | EUR |